Northwest Biotherapeutics (NWBO) Goodwill & Intangibles (2020 - 2026)

Northwest Biotherapeutics' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $52.7 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles rose 2646.3% year-over-year to $52.7 million; the TTM figure through Mar 2026 stood at $52.7 million (up 2646.3% YoY), while the FY2025 annual figure was $53.8 million, up 2705.74% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $52.7 million, down from $53.8 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $53.8 million in Q4 2025, with the low at $1.9 million in Q1 2022.
• The 5-year median for Goodwill & Intangibles is $1.9 million (2022), against an average of $8.0 million.
• The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles changed 0.0% in 2022, then jumped 2705.74% in 2025.
• Northwest Biotherapeutics' Goodwill & Intangibles stood at $1.9 million in 2022, then changed by 0.0% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then surged by 2705.74% to $53.8 million in 2025, then dropped by 2.12% to $52.7 million in 2026.
• Business Quant data shows NWBO's Goodwill & Intangibles at $52.7 million in Q1 2026, $53.8 million in Q4 2025, and $1.9 million in Q3 2025.